Pregnancy: Femoston is not indicated during pregnancy. If pregnancy occurs during medication with Femoston, the medication must be withdrawn immediately.
The results of most epidemiological studies to date relevant to inadvertent fetal exposure to combinations of oestrogens with progestogens indicate no teratogenic or fetotoxic effect.
There are no adequate data from the use of estradiol/dydrogesterone in pregnant women.
Lactation: Femoston is not indicated during lactation.